Lazard Research & Insights


Back Clear all Clear

Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.


April 07, 2025

Lazard Healthcare Services Leaders Study 2025

Lazard Healthcare Services Leaders Study 2025

September 25, 2024

Lazard Global Biopharmaceutical Leaders Study 2024

Biopharmaceutical and biotech investors concluded the summer of 2024 facing ongoing uncertainty.